THE USE OF AUTOLOGOUS BLOOD PRODUCTS IN TEMPOROMANDIBULAR JOINT DISORDERS

Öz

Temporomandibular joint (TMJ) disorders are a multifactorial group of conditions that adversely affect essential functions such as chewing, speaking, and swallowing, thereby negatively impacting quality of life. Conventional treatment methods are limited and mainly provide symptomatic relief. Consequently, interest in biological agents, such as autologous blood products, has increased in recent years. This review examines the effectiveness of autologous blood products, including platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and injectable PRF (I-PRF), in the treatment of TMJ disorders. Clinical studies have shown that the use of autologous blood products in the TMJ plays an effective role in reducing inflammation, improving jaw function, and controlling pain. It has been demonstrated that autologous blood products are effective as an alternative therapeutic option, both when used alone and in combination with procedures such as arthrocentesis.

Anahtar Kelimeler

• Injectable PRF (I-PRF)
• Autologous blood products
• Temporomandibular joint disorders
• Platelet Rich Fibrin (PRF)
• Platelet Rich Plazma (PRP)

TEMPOROMANDİBULAR EKLEM HASTALIKLARINDA OTOLOG KAN ÜRÜNLERİNİN KULLANIMI

Öz

Temporomandibular eklem (TME) rahatsızlıkları, çiğneme, konuşma ve yutma gibi temel fonksiyonları olumsuz etkileyen, multifaktöriyel bir rahatsızlık grubu olup yaşam kalitesini olumsuz etkileyen yaygın bir problemdir. Geleneksel tedavi yöntemleri sınırlı olup semptomatik rahatlama sağlamaktadır. Bu nedenle son yıllarda otolog kan ürünleri gibi biyolojik ajanlara olan ilgi artmıştır. Bu derlemede, trombositten zengin plazma (PRP), trombositten zengin fibrin (PRF) ve enjekte edilebilir PRF (I-PRF) gibi otolog kan ürünlerinin TME rahatsızlıklarının tedavisindeki etkinliği incelenmiştir. Yapılan klinik çalışmalarda otolog kan ürünlerinin temporomandibular eklemde kullanımının enflamasyonun azalmasında, çene fonksiyonlarının iyileşmesinde ve ağrının kontrol altına alınmasında etkin rol oynadığı ortaya konulmuştur. Otolog kan ürünlerinin hem tek başına hem de artrosentez gibi yöntemlerle birlikte kullanımının etkili bir alternatif yöntem olduğu gösterilmiştir.

Anahtar Kelimeler

• Enjekte edilebilir PRF (I-PRF)
• Otolog kan ürünleri
• Temporomandibular eklem bozuklukları
• Trombositten zengin fibrin (PRF)
• Trombositten zengin plazma (PRP)

Kaynakça

1. Kaynaklar Abd El Raouf, M., Wang, X., Miusi, S., Chai, J., Abd El-Aal, A. B. M., Helmy, M. N., & Gaber, K. (2019). Injectable platelet-rich fibrin using the low-speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma. Platelets, 30(2), 213–221. https://doi.org/10.1080/09537104.2017.1401058
2. Akkaş, E., & Esen, A. (2024). Which of the autologous blood products administered simultaneously with arthrocentesis is more effective in terms of clinical outcomes? Journal of Stomatology, Oral and Maxillofacial Surgery, 125(5S1), 101998. https://doi.org/10.1016/j.jormas.2024.101998
3. Al-Barakani, F. H., Fageeh, H. N., Al-Shehri, H. A., & Halboub, E. (2024). A comparative study of the effects of advanced platelet-rich fibrin and resorbable collagen membrane in conjunction with pinhole surgical technique in the management of gingival recession: A split-mouth randomized clinical trial. Head & Face Medicine, 20(1), 9. https://doi.org/10.1186/s13005-024-00441-1
4. Al-Moraissi, E. A., Wolford, L. M., Ellis, E., & Neff, A. (2020). The hierarchy of different treatments for arthrogenous temporomandibular disorders: A network meta-analysis of randomized clinical trials. Journal of Cranio-Maxillofacial Surgery, 48(1), 9–23. https://doi.org/10.1016/j.jcms.2019.10.004
5. Arora, S., & Agnihotri, N. (2017). Platelet derived biomaterials for therapeutic use: Review of technical aspects. Indian Journal of Hematology and Blood Transfusion, 33(2), 159–167. https://doi.org/10.1007/s12288-016-0669-8
6. Bilginaylar, K., & Uyanik, L. O. (2016). Evaluation of the effects of platelet-rich fibrin and piezosurgery on outcomes after removal of impacted mandibular third molars. British Journal of Oral and Maxillofacial Surgery, 54(6), 629–633. https://doi.org/10.1016/j.bjoms.2016.03.016
7. Bousnaki, M., Bakopoulou, A., & Koidis, P. (2018). Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: A systematic review. International Journal of Oral and Maxillofacial Surgery, 47(2), 188–198. https://doi.org/10.1016/j.ijom.2017.09.014
8. Checinski, M., Checinska, K., Turosz, N., Brzozowska, A., Chlubek, D., & Sikora, M. (2023). Current research directions on temporomandibular joint intra-articular injections: A mapping review. Journal of Clinical Medicine, 12(14), 4655. https://doi.org/10.3390/jcm12144655

9. Choukroun, J., Diss, A., Simonpieri, A., Girard, M. O., Schoeffler, C., Dohan, S. L., & Dohan, D. M. (2006a). Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part 1: Technological concepts and evolution. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 101(3), e37–e44. https://doi.org/10.1016/j.tripleo.2005.07.008
10. Choukroun, J., Diss, A., Simonpieri, A., Giraud, M. O., Schoeffler, C., Dohan, S. L., & Dohan, D. M. (2006b). Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 101(3), e56–e60. https://doi.org/10.1016/j.tripleo.2005.07.011
11. Choukroun, J., Diss, A., Simonpieri, A., Girard, M. O., Schoeffler, C., Dohan, S. L., & Dohan, D. M. (2006c). Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 101(3), 299–303. https://doi.org/10.1016/j.tripleo.2005.07.012
12. Dasukil, S., Arora, G., Boyina, K. K., Jena, A. K., Jose, A., & Das, S. (2022). Intra-articular injection of hyaluronic acid versus platelet-rich plasma following single puncture arthrocentesis for the management of internal derangement of TMJ: A double-blinded randomised controlled trial. Journal of Cranio-Maxillofacial Surgery, 50(11), 825–830. https://doi.org/10.1016/j.jcms.2022.10.002
13. De Leeuw, R., & Klasser, G. D. (2018). Orofacial pain: Guidelines for assessment, diagnosis, and management. Quintessence Publishing.
14. Dohle, E., El Bagdadi, K., Sader, R., & Choukroun, J. (2024). Platelet rich fibrin as a bioactive matrix with pro-osteogenic properties. Platelets, 35(1), 213–223. https://doi.org/10.1080/09537104.2024.2316744
15. El-Anwar, M. W., Nofal, A. A. F., Khalifa, M., & Quriba, A. S. (2016). Use of autologous platelet-rich plasma in complete cleft palate repair. The Laryngoscope, 126(7), 1524–1528. https://doi.org/10.1002/lary.25868
16. El Sabbahy, S., El Shehaby, Y., & Salem, M. (2025). Evaluation of clinical effects of platelet-rich plasma as an adjunctive to non-surgical periodontal therapy in treatment of periodontitis patients: A randomized controlled clinical trial. International Journal of Dentistry, 2025, 1–9.
17. Elsamna, S. T., Alqudrah, F., Khan, M., Smith, T., Robitschek, J., & Toman, J. (2025). Platelet rich products in cleft palate repair. Cleft Palate–Craniofacial Journal. Advance online publication. https://doi.org/10.1177/10556656251342003
18. Emara, D., Makeen, K., Aboulhassan, M., & Noureldin, M. (2020). PRP injection effect on palatal fistula repair: A comparative study. The Egyptian Journal of Plastic and Reconstructive Surgery, 44(2), 337–344. https://doi.org/10.21608/ejprs.2020.79727
19. Farshidfar, N., Amiri, M. A., Jafarpour, D., Hamedani, S., Niknezhad, S. V., & Tayebi, L. (2022). The feasibility of injectable PRF (I-PRF) for bone tissue engineering and its application in oral and maxillofacial reconstruction: From bench to chairside. Biomaterials Advances, 134, 112557. https://doi.org/10.1016/j.msec.2021.112557
20. Femminella, B., Iaconi, M. C., Di Tullio, M., Romano, L., Sinjari, B., D’Arcangelo, C., & Caputi, S. (2016). Clinical comparison of platelet-rich fibrin and a gelatin sponge in the management of palatal wounds after epithelialized free gingival graft harvest: A randomized clinical trial. Journal of Periodontology, 87(2), 103–113. https://doi.org/10.1902/jop.2015.150198
21. Giannelli, A., Forte, M., D'Albis, G., Cianciotta, G., Limongelli, L., Stef, L., Feier, R., Alrashadah, A. O., Corsalini, M., & Capodiferro, S. (2025). Utilization of Platelet-Rich Plasma in Oral Surgery: A Systematic Review of the Literature. Journal of Clinical Medicine, 14(8), 2844. https://doi.org/10.3390/jcm14082844
22. Goswami, P., Chaudhary, V., Arya, A., Verma, R., Vijayakumar, G., & Bhavani, M. (2024). Platelet-rich fibrin (PRF) and its application in dentistry: A literature review. Journal of Pharmaceutical and Bioallied Sciences, 16(1), S5–S7. https://doi.org/10.4103/jpbs.jpbs_435_23
23. Hajibagheri, P., Basirat, M., Tabari-Khomeiran, Z., & Asadi-Aria, A. (2025). The efficacy of platelet-rich fibrin (PRF) in post-extraction hard and soft tissue healing and associated complications: A systematic review and meta-analysis of split-mouth randomized clinical trials. BMC Oral Health, 25, 869. https://doi.org/10.1186/s12903-025-06238-1
24. Iodice, G., Cimino, R., Vollaro, S., Lobbezoo, F., & Michelotti, A. (2024). Prevalence of psychosocial findings and their correlation with temporomandibular disorder symptoms. Progress in Orthodontics, 25(1), 7. https://doi.org/10.1186/s40510-024-00538-y
25. Işık, G., & Kenç, S. (2023). Does the use of injectable platelet-rich fibrin after arthrocentesis for disc displacement without reduction improve clinical outcomes? Journal of Oral and Maxillofacial Surgery, 81(6), 689–697. https://doi.org/10.1016/j.joms.2023.02.014
26. Işık, G., Kenç, S., Özveri Koyuncu, B., Günbay, S., & Günbay, T. (2022). Injectable platelet-rich fibrin as treatment for temporomandibular joint osteoarthritis: A randomized controlled clinical trial. Journal of Cranio-Maxillofacial Surgery, 50(7), 576–582. https://doi.org/10.1016/j.jcms.2022.06.006
27. Katz, M. S., Ooms, M., Heitzer, M., Steiner, T., Bock, A., Peters, F., Hölzle, F., & Modabber, A. (2024). Platelet-rich fibrin as a hemostatic agent in dental extractions in patients taking anticoagulants or antiplatelet medication: a systematic review. Clinical Oral Investigations, 28(11), 587. https://doi.org/10.1007/s00784-024-05983-x
28. Keçeli, H. G., Sengun, D., Berberoğlu, A., & Karabulut, E. (2008). Use of platelet gel with connective tissue grafts for root coverage: A randomized-controlled trial. Journal of Clinical Periodontology, 35(3), 255–262. https://doi.org/10.1111/j.1600-051X.2007.01181.x
29. Kaur, H., Samal, S., Vassou, V. M., & Bhatia, G. (2023). Platelet rich plasma (PRP) augmentation: A novel approach in management of radicular cyst present at different locations within jaw: A case series. Journal of Clinical Cases and Reports, 6(Suppl 14), 1074. https://doi.org/10.46619/joccr.2023.6-S14-1074
30. Kour, P., Pudakalkatti, P. S., Vas, A. M., Das, S., & Padmanabhan, S. (2018). Comparative evaluation of antimicrobial efficacy of platelet-rich plasma, platelet-rich fibrin, and injectable platelet-rich fibrin on the standard strains of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. Contemporary Clinical Dentistry, 9(Suppl 2), S325–S330. https://doi.org/10.4103/ccd.ccd_367_18
31. Kumar, N., Francis, M., Sindhu, V. K., Ramachandra, V., Anilkumar, P. V., & Khan, M. F. (2024). Efficacy of injectable platelet-rich fibrin (I-PRF) in managing temporomandibular joint pain: A prospective clinical study. Cureus, 16(2), e54367. https://doi.org/10.7759/cureus.54367
32. Li, H., Xia, T., Zeng, H., Qiu, Y., Wei, Y., Cheng, Y., & Li, B. (2023). Liquid platelet-rich fibrin produced via horizontal centrifugation decreases the inflammatory response and promotes chondrocyte regeneration in vitro. Frontiers in Bioengineering and Biotechnology, 11, 1301430. https://doi.org/10.3389/fbioe.2023.1301430
33. Mihaylova, Z., Mitev, V., Stanimirov, P., Isaeva, A., Gateva, N., & Ishkitiev, N. (2017). Use of platelet concentrates in oral and maxillofacial surgery: An overview. Acta Odontologica Scandinavica, 75(1), 1–11. https://doi.org/10.1080/00016357.2016.1236985
34. Miron, R. J., Fujioka-Kobayashi, M., Hernandez, M., Kandalam, U., Zhang, Y., Ghanaati, S., & Choukroun, J. (2017). Injectable platelet-rich fibrin (I-PRF): Opportunities in regenerative dentistry. Clinical Oral Investigations, 21(8), 2619–2627. https://doi.org/10.1007/s00784-017-2063-9
35. Miron, R. J., Gruber, R., Farshidfar, N., Sculean, A., & Zhang, Y. (2024). Ten years of injectable platelet-rich fibrin. Periodontology 2000, 94(1), 92–113. https://doi.org/10.1111/prd.12538
36. Munoz, F., Jimenez, C., Espinoza, D., Vervelle, A., Beugnet, J., & Haidar, Z. (2016). Use of leukocyte and platelet-rich fibrin (L-PRF) in periodontally accelerated osteogenic orthodontics (PAOO): Clinical effects on edema and pain. Journal of Clinical and Experimental Dentistry, 8(2), e119–e124. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808304/
37. Nitzan, D. W., Dolwick, M. F., & Martinez, G. A. (1991). Temporomandibular joint arthrocentesis: A simplified treatment for severe limited mouth opening. Journal of Oral and Maxillofacial Surgery, 49(11), 1163–1167.
38. Nordenflycht, D., & Tesch, R. (2022). Advantages of ultrasound guidance for TMJ arthrocentesis and intra-articular injection: A narrative review. Dental and Medical Problems, 59(4), 647–656. https://pubmed.ncbi.nlm.nih.gov/36583838/
39. Okeson, J. P. (2021). Management of temporomandibular disorders and occlusion (9th ed.). Elsevier.
40. Pihut, M., & Gala, A. (2020). The application of intra-articular injections for management of the consequences of disc displacement without reduction. International Journal of Environmental Research and Public Health, 17(13), 4726. https://doi.org/10.3390/ijerph17134726
41. Qiu, P., Zhang, X., Cao, R., Xu, H., Jiang, Z., & Lei, J. (2024). Assessment of the efficacy of autologous blood preparations in maxillary sinus floor elevation surgery: A systematic review and meta-analysis. BMC Oral Health, 24, 1171. https://doi.org/10.1186/s12903-024-04938-8
42. Roh, Y. H., Kim, W., Park, K. U., & Oh, J. H. (2016). Cytokine-release kinetics of platelet-rich plasma according to various activation protocols. Bone & Joint Research, 5(2), 37–45. https://doi.org/10.1302/2046-3758.52.2000540
43. Ranjbar Moghaddam, M., Merajikhah, A., Mahdood, B., Mousavi, E., & Bastami, M. (2025). Analyzing outcomes of platelet-rich plasma usage on surgical wounds: A systematic review. Current Problems in Surgery, 64, 101704. https://doi.org/10.1016/j.cpsurg.2024.101704
44. Sielski, M., Chęcińska, K., Chęciński, M., & Sikora, M. (2023). Injectable platelet-rich fibrin (I-PRF) administered to temporomandibular joint cavities: A scoping review. Journal of Clinical Medicine, 12(9), 3326. https://doi.org/10.3390/jcm12093326
45. Singh, A., Sinha, R., Jha, R., & Singh, S. (2025). Efficacy of platelet-rich plasma in post-extraction healing. Journal of Pharmacy & Bioallied Sciences, 17(3), 536–542. https://pmc.ncbi.nlm.nih.gov/articles/PMC12102747/
46. Slade, G. D., Fillingim, R. B., Sanders, A. E., Bair, E., Greenspan, J. D., Ohrbach, R., Dubner, R., Diatchenko, L., Smith, S. B., Knott, C., & Maixner, W. (2013). Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: Implications and future directions. The Journal of Pain, 14(12 Suppl), T116–T124. https://doi.org/10.1016/j.jpain.2013.09.010
47. Vingender, S., Dőri, F., Schmidt, P., Hermann, P., & Vaszilkó, M. T. (2023). Evaluation of the efficiency of hyaluronic acid, PRP and I-PRF intra-articular injections in the treatment of internal derangement of the temporomandibular joint: A prospective study. Journal of Cranio-Maxillofacial Surgery, 51(1), 1–6. https://doi.org/10.1016/j.jcms.2023.01.017
48. Vladulescu, A. M., Balcangiu-Stroescu, A. E., Balan, D. G., Tarmure, V., & Mihai, C. T. (2023). Platelet-rich plasma (PRP) in dermatology: From theoretical aspects to clinical practice. Biomedicines, 12(1), 7. https://doi.org/10.3390/biomedicines12010007
49. Wang, X., Zhang, Y., Choukroun, J., Ghanaati, S., & Miron, R. J. (2018). Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets, 29(1), 48–55. https://doi.org/10.1080/09537104.2017.1293807
50. Xu, J., Gou, L., Zhang, P., Li, H., & Qiu, S. (2020). Platelet-rich plasma and regenerative dentistry. Australasian Dental Journal, 65(2), 131–142. https://doi.org/10.1111/adj.12754
51. Xu, J., Ren, H., Zhao, S., Li, Q., Li, C., Bao, G., & Kang, H. (2023). Comparative effectiveness of hyaluronic acid, platelet-rich plasma, and platelet-rich fibrin in treating temporomandibular disorders: A systematic review and network meta-analysis. Head & Face Medicine, 19(1), 39. https://doi.org/10.1186/s13005-023-00369-y
52. Xu, L., Ding, Y., Lei, C., & Jiang, W. (2014). The use of advance platelet-rich fibrin during immediate implantation for the esthetic replacement of maxillary anterior segment with chronic apical lesion. International Journal of Scientific Research, 3(9), 1368–1372. https://www.ijsr.net/getabstract.php?paperid=SEP14194
53. Yuce, E., & Komerik, N. (2020). Comparison of the efficacy of intra-articular injection of liquid platelet-rich fibrin and hyaluronic acid in conjunction with arthrocentesis for the treatment of internal temporomandibular joint derangements. Journal of Craniofacial Surgery, 31(7), 1870–1874. https://doi.org/10.1097/SCS.0000000000006545
54. Zieliński, A., & Pająk-Zielińska, K. (2024). Association between estrogen levels and temporomandibular disorders: An updated systematic review. International Journal of Molecular Sciences, 25(18), 9867. https://doi.org/10.3390/ijms25189867.